Krystal Biotech, Inc. Operating Lease, Liability
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-03
- 2026-06-30: Operating Lease, Liability $8.85M.
- 2026-03-31: Operating Lease, Liability $9.11M.
- 2025-12-31: Operating Lease, Liability $9.34M.
- 2025-09-30: Operating Lease, Liability $9.51M.
| Period end | Operating Lease, Liability | Operating Lease, Liability as first filed |
|---|---|---|
| 2026-06-30 | $8.85M 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $9.11M 10-Q · filed 2026-05-04 | |
| 2025-12-31 | $9.34M 10-K · filed 2026-02-17 | |
| 2025-09-30 | $9.51M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $9.68M 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $9.66M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $7.26M 10-K · filed 2025-02-19 | |
| 2024-09-30 | $7.48M 10-Q · filed 2024-11-04 | |
| 2024-06-30 | $7.69M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $7.89M 10-Q · filed 2024-05-06 | |
| 2023-12-31 | $8.09M 10-K · filed 2024-02-26 | |
| 2023-09-30 | $8.32M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $8.54M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $8.76M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $8.93M 10-K · filed 2024-02-26 | |
| 2022-09-30 | $9.12M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $9.13M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $9.29M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $8.02M 10-K · filed 2023-02-27 | |
| 2021-09-30 | $8.10M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $7.83M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $3.87M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $3.95M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $3.10M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $3.16M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $3.95M 10-Q · filed 2021-05-10 | $3.21M 10-Q · filed 2020-05-04 |
| 2019-12-31 | $3.26M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $3.32M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $3.36M 10-Q · filed 2020-08-07 | |
| 2019-03-31 | $3.40M 10-Q · filed 2019-05-07 | |
| 2019-01-01 | $1.40M 10-Q · filed 2020-11-09 |